☰ Menu

We are pleased to launch the 2024 conference programme.

Thursday 21 November

11.00amRegistration, welcome refreshments, exhibition and poster viewing
11.25amWelcome and introduction
Dr Fiona McDonald, Consultant Thoracic Clinical Oncologist, The Royal Marsden NHS Foundation Trust & Chair, UK SABR Consortium
11.30amSABR for primary RCC – ready for Primetime?
Professor Shankar Siva, Radiation Oncologist at the Peter MacCallum Cancer Centre, Australia
12.00pmMargins and heart dose constraints for lung SABR
Professor Marcel van Herk, Radiotherapy Physics, The University of Manchester
12.30pmSponsored session
Speaker tba
1.00pmLunch, exhibition and poster viewing
2.00pmProffered papers in the spotlight
2.50pmSponsored session supported by Varian
Speaker tba
3.20pmRefreshments, exhibition and poster viewing
3.50pmTrials update – RTTQA
Patricia Diez, Lead Clinical Scientist, RTTQA & Dr Rushil Patel, Lead SABR Physicist, RTTQA, Mount Vernon Cancer Centre
4.20pmMDT session – challenging cases
Led by Professor Shankar Siva and an expert panel of speakers
5.00pmSABR for metastatic disease: What does the future hold?
Dr David Palma, Radiation Oncologist, London Health Sciences Centre, London, Ontario, Canada
5.30pmClose of Day One

Friday 22 November

9.00amRegistration, welcome refreshments, exhibition and poster viewing
9.25amWelcome and introduction
Dr Chris Dean, Lead Stereotactic Radiotherapy Physicist, Barts Health NHS Trust & Vice-Chair, UK SABR Consortium
9.30amSponsored session
Speaker tba
10.00amCurrent role of SABR in prostate cancer
Dr Alison Tree, Consultant Clinical Oncologist, The Royal Marsden NHS Foundation Trust and Professor Nick van As, Consultant Clinical Oncologist, The Royal Marsden NHS Foundation Trust
10.30amUpdate on SABR for primary lung including ILD and ultra central
Dr David Palma, Radiation Oncologist, London Health Sciences Centre, London, Ontario, Canada
11.00amRefreshments, exhibition and poster viewing
11.30amSABR treatments for head and neck
Speakers tba
12.00pmTechnicalities of non-spine bone SABR
Emma Dunne, Clinical Assistant Professor, Radiation Oncology, Provincial Health Services Authority, Vancouver, Canada (invited)
12.30pmProffered papers in the spotlight
1.20pmLunch, exhibition and poster viewing
2.20pmSponsored session
Speaker tba
2.50pmDebate – this house believes that in 5 years’ time SABR will offer more to patients with metastatic disease than SACT
Against the motion: Dr Tom Newson-Davies, Consultant Medical Oncologist
Chelsea & Westminster Hospital and Dr Clive Peedell, Consultant Clinical Oncologist, James Cook University Hospital, Middlesborough
For the motion: Dr Aidan Cole, Consultant Oncologist and Senior Lecturer, Queen’s University Belfast and Professor Gerry Hanna, Clinical Director for Oncology, Northern Ireland Cancer Centre Belfast
3.30pmClosing remarks